Orgul Gokcen, Ayhan Sule Goncu, Saracoglu Gulhan Cetinkaya, Yucel Aykan
Department of Perinatology, University of Health Sciences, Ankara, Turkey.
Rev Bras Ginecol Obstet. 2021 Jan;43(1):9-13. doi: 10.1055/s-0040-1721355. Epub 2021 Jan 29.
We evaluated risk factors to determine if there were specific risk factors that could predict massive bleeding in nulliparous women with placenta previa.
The participants were classified into two groups. Women with a calculated blood loss ≥ 1,000 mL were included in the massive bleeding group. Women without any signs or symptoms related with hypovolemia or with a calculated bleeding volume < 1,000 mL were categorized into the non-massive bleeding group.
There were 28 patients (40.6%) with massive bleeding and 41 cases (59.4%) with non-massive bleeding. The calculated blood loss and number of cases that required red cell transfusions were statistically different between the groups (< 0.005 and 0.002, respectively). There were no statistically significant differences in terms of maternal or fetal factors, placental location, or delivery characteristics between the two groups.
We could not determine the predictive features for massive hemorrhage based on clinical features, delivery features, or placental location.
我们评估了风险因素,以确定是否存在能够预测前置胎盘初产妇大出血的特定风险因素。
将参与者分为两组。计算失血量≥1000毫升的女性被纳入大出血组。没有任何与血容量不足相关的体征或症状或计算出血量<1000毫升的女性被归类为非大出血组。
有28例(40.6%)大出血患者和41例(59.4%)非大出血患者。两组之间计算的失血量和需要红细胞输血的病例数在统计学上存在差异(分别<0.005和0.002)。两组在母体或胎儿因素、胎盘位置或分娩特征方面没有统计学上的显著差异。
我们无法根据临床特征、分娩特征或胎盘位置确定大出血的预测特征。